Galaxy Cosmological Mass Function

We study the galaxy cosmological mass function (GCMF) in a semi-empirical relativistic approach using observational data provided by galaxy redshift surveys. Starting from the theory of Ribeiro & Stoeger (2003, arXiv:astro-ph/0304094) between the mass-to-light ratio, the selection function obtained from the luminosity function (LF) data and the luminosity density, the average luminosity $L$ and the average galactic mass $\mathcal{M}_g$ are computed in terms of the redshift. $\mathcal{M}_g$ is also alternatively estimated by a method that uses the galaxy stellar mass function (GSMF). Comparison of these two forms of deriving the average galactic mass allows us to infer a possible bias introduced by the selection criteria of the survey. We used the FORS Deep Field galaxy survey sample of 5558 galaxies in the redshift range $0.5 < z < 5.0$ and its LF Schechter parameters in the B-band, as well as this sample's stellar mass-to-light ratio and its GSMF data. Assuming ${\mathcal{M}_{g_0}} \approx 10^{11} \mathcal{M}_\odot$ as the local value of the average galactic mass, the LF approach results in $L_{B} \propto (1+z)^{(2.40 \pm 0.03)}$ and $\mathcal{M}_g \propto (1+z)^{(1.1\pm0.2)}$. However, using the GSMF results produces $\mathcal{M}_g \propto (1+z)^{(-0.58 \pm 0.22)}$. We chose the latter result as it is less biased. We then obtained the theoretical quantities of interest, such as the differential number counts, to calculate the GCMF, which can be fitted by a Schechter function. The derived GCMF follows theoretical predictions in which the less massive objects form first, being followed later by more massive ones. In the range $0.5 < z < 2.0$ the GCMF has a strong variation that can be interpreted as a higher rate of galaxy mergers or as a strong evolution in the star formation history of these galaxies.Comment: In memory of William R. Stoeger (1943-2014). LaTeX, 8 pages, 7 figures. Minor changes to match version sent to publisher. To appear in "Astronomy and Astrophysics

Composição química e atividade inibidora de acetilcolinesterase de óleos voláteis de Myrceugenia myrcioides(Cambess.) O. Berg and Eugenia riedeliana O. Berg, Myrtaceae

The chemical composition of volatile oils from two Myrtaceae species, Myrceugenia myrcioidesand Eugenia riedeliana, both native from the Brazilian Atlantic Rain Forest, was analyzed by GC-MS. Acetylcholinesterase inhibitory activity was colorimetrically evaluated for these oils. For M. myrcioides, monoterpene hydrocarbons represented the major class in the volatile oil, with &#945;-pinene as the most abundant component and a weak inhibitory activity was observed, whilst for E. riedeliana sesquiterpenes were found in higher amounts, being valerianol the major compound, and this oil presented a strong acetylcholinesterase inhibition.A composição química dos óleos voláteis de duas espécies de Myrtaceae, Myrceugenia myrcioidese Eugenia riedeliana, ambas nativas da Mata Atlântica, foi analisada por CG-EM. A atividade inibidora de acetilcolinesterase foi determinada colorimetricamente para estes óleos. Em M. myrcioides, hidrocarbonetos monoterpênicos representaram a classe majoritária de compostos presentes no óleo volátil, sendo &#945;-pineno o componente mais abundante e a atividade inibidora de acetilcolinesterase foi baixa, enquanto para E. riedelianaos sesquiterpenos foram observados em maiores concentrações, sendo o valerianol o componente majoritário, e este óleo apresentou uma forte atividade inibidora da enzima.BIOTA/FAPESPCNPqCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES

A large Venous-Arterial PCO2 Is Associated with Poor Outcomes in Surgical Patients

Background. This study evaluated whether large venous-arterial CO2 gap (PCO2 gap) preoperatively is associated to poor outcome. Method. Prospective study which included adult high-risk surgical patients. The patients were pooled into two groups: wide [P(v-a)CO2] versus narrow [P(v-a)CO2]. In order to determine the best value to discriminate hospital mortality, it was applied a ROC (receiver operating characteristic) curve for the [P(v-a)CO2] values collected preoperatively, and the most accurate value was chosen as cut-off to define the groups. Results. The study included 66 patients. The [P(v-a)CO2] value preoperatively that best discriminated hospital mortality was 5.0 mmHg, area = 0.73. Preoperative patients with [P(v-a)CO2] more than 5.0 mmHg presented a higher hospital mortality (36.4% versus 4.5% P = 0.004), higher prevalence of circulatory shock (56.8% versus 22.7% P = 0.01) and acute renal failure postoperatively (27.3% versus 4.5% P = 0.02), and longer hospital length of stays 20.0 (14.0–30.0) versus 13.5 (9.0–25.0) days P = 0.01. Conclusions. The PCO2 gap values more than 5.0 mmHg preoperatively were associated with worse postoperatively outcome

ASPHER Statement: Facing the Fourth Winter of the COVID-19 Pandemic

From Frontiers via Jisc Publications RouterHistory: collection 2022, received 2022-09-14, accepted 2022-09-20, epub 2022-10-03Peer reviewed: TruePublication status: Publishe

Programa Institucional de Bolsa de Iniciação à Docência (Pibid) e a Formação de Professores de Química – Subprojeto UnB/Ceilândia-DF

..

Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial

Background: Low n-3 polyunsaturated fatty acids (PUFAs) has been linked to depression, but the preventive effect of n-3PUFAs supplementation on maternal depression needs further investigation. We aimed to evaluate the efficacy of a daily dose of n-3 PUFAs supplementation (fish oil) on the prevention of postpartum depression (PPD). Methods: A randomized, placebo-controlled, double blind trial was designed and nested into a cohort study conducted in Rio de Janeiro, Brazil. Sixty pregnant women identified as being at risk for PPD were invited and randomly assigned to receive fish oil capsules [1.8 g (1.08 g of Eicosapentaenoic (EPA) and 0.72 g of Docosapentaenoic (DHA) acids)] or placebo (control). The Edinburgh Postnatal Depression Scale (EPDS) was scored at 5–13 (T0, baseline), 22–24 (T1), 30–32 weeks of gestation (T2) and 4–6 weeks’ postpartum (T3). Supplementation started at week 22–24 of gestation (T1) and lasted for 16 weeks. Serum fatty acids were assayed to evaluate compliance. Prevalence of EPDS ≥11 was the primary outcome, and mean and changes in EPDS score, length of gestation, and birth weight the secondary outcomes. Linear mixed-effect (LME) and random-intercept logistic regression models were performed to test the effect of fish oil supplementation on prevalence of EPDS ≥11 and EPDS scores variation. Results: In intention-to-treat (ITT) analysis, at 30–32 weeks’ gestation women in the fish oil presented higher serum concentration of EPA, DHA and lower n-6/n-3 ratio comparing to the control group. There were no differences between intervention and control groups in the prevalence of EPDS ≥11, EPDS scores over time, or in changes in EPDS scores from pregnancy to postpartum in either the ITT or per-protocol analyses. Women in the fish oil group with previous history of depression presented a higher reduction on the EPDS score from the second to the third trimester in the fish oil comparing to the control group in the ITT analyses [−1.0 (−3.0–0.0) vs. -0.0 (−1.0–3.0), P = 0.038). These results were confirmed on the LME model (β = −3.441; 95%CI: -6.532– -0.350, P = 0.029). Conclusion: Daily supplementation of 1.8 g of n-3 PUFAs during 16 weeks did not prevent maternal depressive symptoms in a sample of Brazilian women